Monoklonal Antikorlar tipakademisi.com Dr.

Yavuz SAHIN

Cetuximab Bevacizumab Endotel Hücresi

Transtuzumab Panitumumab Ranibizumab
Pertuzumab
Margetuximab
Necitumumab
Amivantamab Olaratumab
Ramucirumab - VEGFR P
Aflibercept
Pegaptanib
- - - - Sunitinib
Sorafenib
Axitinib
Lenvatinib

PDGFR
EGFR
Pazopanib
HER2

FGFR

FLT3
ALK
Regorafenib

JAK
P P P P P P VEGF
ahin
Y.Ş .
M.D
- - - - - - - ahin
Y.Ş .
M.D
Lapatinib Erlotinib (19del) Avapritinib Pazopanib Alectinib Pacritinib Ruxolitinib Antijen Sunan
Neratinib Gefitinib İmatinib Pemigatinib Ceritinib Lestaurtinib Tofacitinib Hücre
Afatinib Afatinib Pazopanib Erdafitinib Crizotinib Gilteritinib Baricitinib, Upadacitinib
Dacomitinib Ripretinib Entrectinib Midostaurin Fedratinib
Osimertinib (T790M) Brigatinib CD80
Sotorasib (G12C) İdelalisib

Syk bcr abl

VemuRAFenib
RAS PI3K - Kopanlisib
Alpelisib
İpilimumab
Trehelimumab -
İbrutinib CTLA-4
- -
DabRAFenib
EncoRAFenib - BRAF AKT BTK - Acalabrutinib
Zanubrutinib
Fostamatinib
Capmatinib
Imatinib
Dasatinib
Trametinib
Cobimetinib - MEK Bcl-2 - Venetoclax
Nilotinib Selumetinib Relatlimab - LAG-3
- Bosutinib
Ponatinib (T315I)
Binimetinib ERK
Anti-
Apopitozis PD-L1 PD1 T Hücre
c-MET
Abemaciclib
Palbociclib - SiklinD
CDK4/6 Oleparib
Ribociclib
Trilaciclib
DNA
Replikasyonu
DNA Tamiri
PARP
- Niraparib
Rucaparib
- -
Panobinostat Talazaparib
Belinostat, Vorinostat
Romidepsin
- DNA Histon
Deasetilaz Kanser Hücresi
Atezolizumab
Avelumab
Nivolumab
Pembrolizumab
Durvalumab Cemiplimab
Dostarlimab

tipakademisi.com 2022 Tasarım: Dr. Yavuz ŞAHİN

Infliximab, Adalimumab
Certolizumab, Golimumab, - TNF-a ahin
Y.Ş .D.
CD2 - Alefacept

-
M
Etanercept
CD3 Muromonab, Blinatumomab (CD3-CD19)
Anakinra, Canakininumab , Rilonacept - IL-1R
CD4 - İbalizumab
Daklizumab, Basailixmab, Denilökin - IL-2R
CD11a - Efalizumab

Dupilumab - IL-4R CD20 - Rituksimab Tositumomab, İbritumomab,

Ofatumumab, Obinutuzumab, Okrelizumab

Mepolizumab, Reslizumab, Benralizumab (R) - IL-5 Proteosom CD22 - Epratuzumab, inotuzumab, Moxetumomab

Tocilizumab, Sarilumab - IL-6 - CD25 - Basailixmab, Daclizumab

(IL-2R)
Lebrikizumab, Tagraxofusp - IL-13
Bortezomib
Karfilzomib CD30 - Brentuksimab
İksazomib
Brodalumab (R), Sekukinumab, İksekizumab - IL-17 CD33 - Gemtuzumab

Ustekinumab, Guselkumab - IL-23

CD38 - Daratumumab, Isatuximab

CD52 - Alemtuzumab
Emapalumab (INF-g)
Efalizumab - LFA-1
Anifrolumab (IFN-a, b, w)
CD79 - Polatuzumab Teprotumumab

- Natalizumab - VLA-4 (a4-integrin) CD319 - Elotuzumab -

Interferon Vedolizumab - a4b7 integrin EPCAM - Catumaksomab (CD3)
IGF-1R
hin
Belimumab - BLyS
Y.Şa
M .D
.
TGF - Luspatersept

Monoklonal Antikorlar tipakademisi.com Dr.Yavuz SAHIN

 Monoclonal Antibodies Yavuz SAHIN, MD

Cetuximab Bevacizumab Endotel Hücresi

Transtuzumab Panitumumab Ranibizumab
Pertuzumab
Margetuximab
Necitumumab
Amivantamab Olaratumab
Ramucirumab - VEGFR P
Aflibercept
Pegaptanib
- - - - Sunitinib
Sorafenib
Axitinib
Lenvatinib

PDGFR
EGFR
Pazopanib
HER2

FGFR

FLT3
ALK
Regorafenib

JAK
P P P P P P VEGF
ahin
Y.Ş .
M.D
- - - - - - - ahin
Y.Ş .
M.D
Lapatinib Erlotinib (19del) Avapritinib Pazopanib Alectinib Pacritinib Ruxolitinib Antijen Sunan
Neratinib Gefitinib İmatinib Pemigatinib Ceritinib Lestaurtinib Tofacitinib Hücre
Afatinib Afatinib Pazopanib Erdafitinib Crizotinib Gilteritinib Baricitinib, Upadacitinib
Dacomitinib Ripretinib Entrectinib Midostaurin Fedratinib
Osimertinib (T790M) Brigatinib CD80
Sotorasib (G12C) İdelalisib

Syk bcr abl

VemuRAFenib
RAS PI3K - Kopanlisib
Alpelisib
İpilimumab
Trehelimumab -
İbrutinib CTLA-4
- -
DabRAFenib
EncoRAFenib - BRAF AKT BTK - Acalabrutinib
Zanubrutinib
Fostamatinib
Capmatinib
Imatinib
Dasatinib
Trametinib
Cobimetinib - MEK Bcl-2 - Venetoclax
Nilotinib Selumetinib Relatlimab - LAG-3
- Bosutinib
Ponatinib (T315I)
Binimetinib ERK
Anti-
Apopitozis PD-L1 PD1 T Hücre
c-MET
Abemaciclib
Palbociclib - SiklinD
CDK4/6 Oleparib
Ribociclib
Trilaciclib
DNA
Replikasyonu
DNA Tamiri
PARP
- Niraparib
Rucaparib
- -
Panobinostat Talazaparib
Belinostat, Vorinostat
Romidepsin
- DNA Histon
Deasetilaz Kanser Hücresi
Atezolizumab
Avelumab
Nivolumab
Pembrolizumab
Durvalumab Cemiplimab
Dostarlimab

Design by: Yavuz SAHIN, MD

Infliximab, Adalimumab
Certolizumab, Golimumab, - TNF-a ahin
Y.Ş .D.
CD2 - Alefacept

-
M
Etanercept
CD3 Muromonab, Blinatumomab (CD3-CD19)
Anakinra, Canakininumab , Rilonacept - IL-1R
CD4 - Ibalizumab
Daklizumab, Basailixmab, Denilökin - IL-2R
CD11a - Efalizumab

Dupilumab - IL-4R CD20 - Rituksimab Tositumomab, Ibritumomab,

Ofatumumab, Obinutuzumab, Ocrelizumab

Mepolizumab, Reslizumab, Benralizumab (R) - IL-5 Proteasome CD22 - Epratuzumab, inotuzumab, Moxetumomab

Tocilizumab, Sarilumab - IL-6 - CD25 - Basailixmab, Daclizumab

(IL-2R)
Lebrikizumab, Tagraxofusp - IL-13
Bortezomib
Karfilzomib CD30 - Brentuksimab
Ixazomib
Brodalumab (R), Sekukinumab, İksekizumab - IL-17 CD33 - Gemtuzumab

Ustekinumab, Guselkumab - IL-23

CD38 - Daratumumab, Isatuximab

CD52 - Alemtuzumab
Emapalumab (INF-g)
Efalizumab - LFA-1
Anifrolumab (IFN-a, b, w)
CD79 - Polatuzumab Teprotumumab

- Natalizumab - VLA-4 (a4-integrin) CD319 - Elotuzumab -

Interferon Vedolizumab - a4b7 integrin EPCAM - Catumaksomab (CD3)
IGF-1R
hin
Belimumab - BLyS
Y.Şa
M .D
.
TGF - Luspatersept

Monoclonal Antibodies Yavuz SAHIN, MD